In the current study, we demonstrate that CD24 level in peripheral blood leukocytes (PBLs) can be used as a potential marker for the detection of CR neoplasia and examine the possible implications of CD24 genetic variants in the genetic predisposition to CRC. This evidence concerns the gene CD24 and colorectal carcinoma.